Related Experiment Video
Updated: Jul 7, 2026

Working with Human Tissues for Translational Cancer Research
Published on: November 26, 2015
How should adverse events be reported in US clinical trials?: ethical considerations
1Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland, USA. ashamoo@umaryland.edu
Abstract:
Research with human subjects, including clinical trials, forms the cornerstone of the development of knowledge on the safety and efficacy of potential drugs and devices. During the conduct of clinical trials, human subjects may experience adverse events ranging from trivial side effects such as mild discomfort to severe complications, including death. Three of the regulatory criteria set forth in the 45 Code of Federal Regulations 46.111 for approval of research(1) focus on risk assessment and minimization of risks. The accurate and full reporting of these adverse events and the assessment of the risk attributable to participation in research are therefore crucial components in the ethical conduct of research.
Insights
Accurate reporting of adverse events in human subject research, including clinical trials, is vital. This ensures ethical conduct and proper risk assessment for drug and device development.
Area of Science:
- Medical research ethics
- Clinical trial safety
Background:
- Human subject research, including clinical trials, is essential for evaluating drug and device safety and efficacy.
- Adverse events in clinical trials can range from minor side effects to severe complications, including death.
Purpose of the Study:
- To emphasize the critical role of adverse event reporting in ethical research.
- To highlight the importance of risk assessment and minimization in human subject research.
Main Methods:
- Review of regulatory criteria for research approval (45 Code of Federal Regulations 46.111).
- Focus on risk assessment and minimization principles.
Main Results:
- Regulatory criteria mandate a focus on risk assessment and minimization.
- Accurate and complete reporting of adverse events is a key ethical requirement.
Conclusions:
- Thorough adverse event reporting and risk assessment are fundamental to the ethical conduct of research involving human subjects.
- Ensuring participant safety is paramount in all stages of clinical trials and research.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Types of Reports II: Incident or Occurrence Report
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Clinical Trials: Overview
Types of Reports III: Telephone and Verbal Reports
Here's an overview of each type:
Telephone Orders
